IBTR Risk Estimation
IBTR Risk Estimation generates an estimated $0/month in revenue from 0 downloads/month on the App Store, according to AppCurrents estimates (updated 2026-06-17).
| Est. revenue / month | $0 |
|---|---|
| Est. downloads / month | 0 |
| Estimate confidence | low |
| Pricing | Paid $2.99 |
| Rating | 0.00 ★ (0 ratings) |
| Category | Medical |
| Released | 08.10.2025 |
| App last updated | 29.12.2025 |
| Platform | iOS |
Modeled monthly estimate · rating velocity · low confidence
About
This application is a tool to estimate the risk of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery. It provides 10-year IBTR risk estimates and treatment effects, based on clinicopathological factors (age, pathological T stage, grade, margin status, lymphovascular invasion, hormone receptor status, HER2 status) and treatment options (radiation therapy, chemotherapy, endo…
Trends & analysis
Chart rank trend
US · overallWhy it's surfacing
Scout 21Ratings & velocity
★ 0 in windowGeographic reach
best rank · 1 storefrontRevenue & downloads trend
monthly estimateUpdate history
1 update tracked- v1.55mo ago
Updated the Age Rating settings.
IBTR Risk Estimation — FAQ
How many downloads does IBTR Risk Estimation get?
IBTR Risk Estimation sees an estimated 0 downloads per month on the App Store, per AppCurrents modeling.
Is IBTR Risk Estimation free?
IBTR Risk Estimation is a paid app priced at $2.99 on the App Store.
When was IBTR Risk Estimation released?
IBTR Risk Estimation launched on the App Store on 08.10.2025. Its latest version shipped 29.12.2025.
Apps like IBTR Risk Estimation
See all alternatives →
Huckleberry: Baby & ChildMedical · $460k–$1.9M/mo
Human Anatomy Atlas 2026Medical · $330k–$1.4M/mo
epocrates: Drug Info & Pill IDMedical · $310k–$1.3M/mo
Baby Tracker - Newborn LogMedical · $200k–$810k/mo
SnoreLab : Record Your SnoringMedical · $140k–$570k/mo
Prepry - ARDMS & CCI Exam PrepMedical · $110k–$460k/mo